Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China flag China · Delayed Price · Currency is CNY
271.48
+2.10 (0.78%)
At close: Mar 20, 2026

SHA:688506 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
2,5205,821560.42701.83794.95
Other Revenue
-1.671.461.451.78
2,5205,823561.87703.28796.73
Revenue Growth (YoY)
-56.72%936.31%-20.11%-11.73%-21.33%
Cost of Revenue
-283.74242.26237.7203.39
Gross Profit
2,5205,539319.61465.58593.34
Selling, General & Admin
-405.04367.89403.01467.46
Research & Development
-1,443746.23375.02278.6
Other Operating Expenses
3,2384.24-2.279.799.17
Operating Expenses
3,2381,8531,105795.41752.86
Operating Income
-717.993,686-785.6-329.83-159.52
Interest Expense
--42.52-24.68-22.48-8.69
Interest & Investment Income
-225.325.710.773.61
Currency Exchange Gain (Loss)
-63.88-1.11-0.05-0.14
Other Non Operating Income (Expenses)
-1.12-3.38-0.84-0.56-0.35
EBT Excluding Unusual Items
-719.113,930-806.51-352.16-165.09
Gain (Loss) on Sale of Investments
-11.44---
Gain (Loss) on Sale of Assets
--0.22-0.14-0.48-0.45
Other Unusual Items
-37.337.6463.5761.1
Pretax Income
-719.113,978-769.01-289.07-104.44
Income Tax Expense
331.55270.6511.49-6.69-4.45
Earnings From Continuing Operations
-1,0513,708-780.5-282.38-99.99
Net Income
-1,0513,708-780.5-282.38-99.99
Net Income to Common
-1,0513,708-780.5-282.38-99.99
Shares Outstanding (Basic)
414401400362357
Shares Outstanding (Diluted)
414401400362357
Shares Change (YoY)
3.20%0.14%10.56%1.38%3.64%
EPS (Basic)
-2.549.25-1.95-0.78-0.28
EPS (Diluted)
-2.549.25-1.95-0.78-0.28
Free Cash Flow
-3,975-697.29-293.21-179.63
Free Cash Flow Per Share
-9.92-1.74-0.81-0.50
Gross Margin
100.00%95.13%56.88%66.20%74.47%
Operating Margin
-28.49%63.31%-139.82%-46.90%-20.02%
Profit Margin
-41.69%63.67%-138.91%-40.15%-12.55%
Free Cash Flow Margin
-68.26%-124.10%-41.69%-22.55%
EBITDA
-650.093,754-727.25-272.27-109.37
EBITDA Margin
-25.80%64.48%-129.43%-38.71%-13.73%
D&A For EBITDA
67.967.958.3457.5650.16
EBIT
-717.993,686-785.6-329.83-159.52
EBIT Margin
-28.49%63.31%-139.82%-46.90%-20.02%
Effective Tax Rate
-6.80%---
Revenue as Reported
-5,823561.87703.28796.73
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.